These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 21736911)
1. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease. Ozsoy O; Seval-Celik Y; Hacioglu G; Yargicoglu P; Demir R; Agar A; Aslan M Neurochem Int; 2011 Oct; 59(5):664-70. PubMed ID: 21736911 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167 [TBL] [Abstract][Full Text] [Related]
3. Neuronal nitric oxide synthase phosphorylation induced by docosahexaenoic acid protects dopaminergic neurons in an experimental model of Parkinson's disease. Parlak H; Ozkan A; Dilmac S; Tanriover G; Ozsoy O; Agar A Folia Histochem Cytobiol; 2018; 56(1):27-37. PubMed ID: 29577226 [TBL] [Abstract][Full Text] [Related]
4. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697 [TBL] [Abstract][Full Text] [Related]
5. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Choi JY; Jang EH; Park CS; Kang JH Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991 [TBL] [Abstract][Full Text] [Related]
6. Antioxidant responses and lipid peroxidation following intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats: increased susceptibility of olfactory bulb. Franco J; Prediger RD; Pandolfo P; Takahashi RN; Farina M; Dafre AL Life Sci; 2007 Apr; 80(20):1906-14. PubMed ID: 17382353 [TBL] [Abstract][Full Text] [Related]
7. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Mu X; He GR; Yuan X; Li XX; Du GH Pharmacol Biochem Behav; 2011 Apr; 98(2):286-91. PubMed ID: 21262257 [TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909 [TBL] [Abstract][Full Text] [Related]
10. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice. Ren JP; Zhao YW; Sun XJ Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141 [TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease. Hacioglu G; Seval-Celik Y; Tanriover G; Ozsoy O; Saka-Topcuoglu E; Balkan S; Agar A Folia Histochem Cytobiol; 2012 Jul; 50(2):228-38. PubMed ID: 22763967 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity. Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147 [TBL] [Abstract][Full Text] [Related]
13. The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B. Ozsoy O; Tanriover G; Derin N; Uysal N; Demir N; Gemici B; Kencebay C; Yargicoglu P; Agar A; Aslan M Neurotox Res; 2011 Oct; 20(3):250-62. PubMed ID: 21234736 [TBL] [Abstract][Full Text] [Related]
14. Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease. Khan MM; Hoda MN; Ishrat T; Ahmad A; Khan MB; Khuwaja G; Raza SS; Safhi MM; Islam F Behav Pharmacol; 2010 Sep; 21(5-6):563-71. PubMed ID: 20657266 [TBL] [Abstract][Full Text] [Related]
15. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Shin JY; Park HJ; Ahn YH; Lee PH J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187 [TBL] [Abstract][Full Text] [Related]
17. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Rajeswari A Eur Rev Med Pharmacol Sci; 2006; 10(4):157-61. PubMed ID: 16910344 [TBL] [Abstract][Full Text] [Related]
18. The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease. Tanriover G; Seval-Celik Y; Ozsoy O; Akkoyunlu G; Savcioglu F; Hacioglu G; Demir N; Agar A Folia Histochem Cytobiol; 2010 Sep; 48(3):434-41. PubMed ID: 21071351 [TBL] [Abstract][Full Text] [Related]
19. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease. Zhao Q; Gao J; Li W; Cai D Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277 [TBL] [Abstract][Full Text] [Related]
20. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease]. Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]